Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies
NCT06801002
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
JBZ-001
Sponsor
Jabez Bioscience, Inc